Analogously, clinically relevant mutations of NaCT that result in the insufficient transport of citrate, and thereby interrupt brain energy metabolism resulting in epileptic encephalopathy, are located on the re-entrant loops and broken helices of the pore region in NaCT [66]. Here, SLC13A5 is linked to Epileptic encephalopathy.